• Inside Immunai: Can artificial intelligence map our immune system?

  • Mar 26 2025
  • Duración: 41 m
  • Podcast

Inside Immunai: Can artificial intelligence map our immune system?

  • Resumen

  • This week, host Eve Young, economics correspondent for The Jerusalem Post, interviews Noam Solomon - CEO and co-founder at Immunai.

    Immunai is a biotechnology company working to comprehensively map and decode the immune system with single-cell biology and AI to make new therapeutic discoveries, accelerate drug development, and improve patient outcomes.

    Noam will talk about how Immunai uses AI and machine learning to make medical advancements, and explain what machine learning is in laymans terms. He will also explain what kind of team is best suited to face the challenges of a complex, deep science problem like mapping human immunity.
    Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Inside Immunai: Can artificial intelligence map our immune system?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.